ZOLL and CAIRE, Inc. Sign Exclusive Agreement for Outside-the-U.S. Distribution of Portable Oxygen Concentrator
Photo/Business Wire
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and CAIRE, Inc., an oxygen supply manufacturer, today announced the signing of an exclusive distributor agreement. As part of this agreement, ZOLL has exclusive rights to distribute the SAROS® 4000 Portable Oxygen Concentrator in all markets outside the U.S. in combination with ZOLL’s EMV+® ventilator.
By combining the EMV+ ventilator with the SAROS 4000 Oxygen Concentrator, remote medics will be able to deliver high-end, oxygen-enriched critical care ventilation and oxygenation therapy without the use of oxygen cylinders, which present refilling and logistical challenges and are a hazardous threat in armed conflicts.
“The logistical burden of exchanging empty oxygen cylinders in the field presents considerable challenges for militaries, including the risk of explosion and the need for aircraft and personnel to transport the cylinders to and from the field,” said Elijah A. White, President of ZOLL Resuscitation. “This is a game-changing advancement for all military medical services and disaster relief organizations in their efforts to provide lifesaving therapies during their missions.”
“SAROS broke new ground as the first and only oxygen concentrator designed specifically for military use,” said Earl Lawson, President and CEO of CAIRE. “Our agreement with ZOLL enables us to increase global access to this important technology. Coupled with the EMV+ ventilator, it will dramatically improve the delivery of care in emergent situations.”
